BIIB - BIOGEN INC.
187.06
-2.220 -1.187%
Share volume: 696,624
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$189.28
-2.22
-0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-01-2024 | 10-30-2024 | 02-12-2025 | 05-01-2025 | 07-31-2025 | 10-30-2025 | 02-06-2026 | 04-29-2026 | |
| Total revenue | 2.465 B | 2.466 B | 2.455 B | 2.431 B | 2.646 B | 2.535 B | 2.279 B | 2.478 B | |
| Cost of revenue | 546.000 M | 638.700 M | 583.500 M | 629.300 M | 605.000 M | 674.400 M | 495.500 M | 661.000 M | |
| Gross profit | 1.919 B | 1.827 B | 1.871 B | 1.802 B | 2.041 B | 1.860 B | 1.784 B | 1.817 B | |
| -4.78% | 2.41% | -3.71% | 13.25% | -8.83% | -4.11% | 1.84% | |||
| Operating expenses | 1.068 B | 1.131 B | 1.212 B | 1.207 B | 1.029 B | 1.033 B | 1.414 B | 1.180 B | |
| Selling general and admin | 553.800 M | 588.400 M | 680.000 M | 572.500 M | 583.800 M | 594.800 M | 682.500 M | 607.300 M | |
| Research and development | 513.900 M | 542.700 M | 532.300 M | 634.800 M | 445.600 M | 438.200 M | 731.800 M | 573.000 M | |
| Total expenses | 1.220 B | 1.376 B | 1.236 B | 1.491 B | 1.297 B | 1.303 B | 1.840 B | 1.439 B | |
| 12.78% | -10.17% | 20.58% | -13.02% | 0.50% | 41.20% | -21.78% | |||
| Operating income | 698.700 M | 451.000 M | 635.100 M | 311.200 M | 744.000 M | 557.300 M | -56.000 M | 377.700 M | |
| Ebit | 698.700 M | 451.000 M | 635.100 M | 311.200 M | 744.000 M | 557.300 M | -56.000 M | 377.700 M | |
| Pretax income | 698.700 M | 451.000 M | 291.500 M | 311.200 M | 744.000 M | 557.300 M | -56.000 M | 377.700 M | |
| -35.45% | -35.37% | 6.76% | 139.07% | -25.09% | -110.05% | -774.46% | |||
| Income tax | 115.100 M | 62.500 M | 24.800 M | 70.700 M | 109.200 M | 90.800 M | -7.100 M | 58.200 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 583.600 M | 388.500 M | 266.700 M | 240.500 M | 634.800 M | 466.500 M | -48.900 M | 319.500 M | |
| -33.43% | -31.35% | -9.82% | 163.95% | -26.51% | -110.48% | 753.37% |